ADGSOM1 & ADGMIN1  
       
  LAUNCH OF THE 50TH ANNIVERSARY CELEBRATION OF RUKUN NEGARA  
       
  KL SUMMIT 2019  
       
  HAWANA 2018  
       
  AES 2016  
       

 
 
 

April 30, 2024 -Tuesday

 
  CLINICAL RESEARCH MALAYSIA BESTOWS ITS INDUSTRY RECOGNITION AWARD TO JEFFREY SCOTT YABLON

Tuesday 22/03/2016



Yablon recognized at the first CRM Industry Dialogue of 2016
 
KUALA LUMPUR, Malaysia, March 22 (Bernama-GLOBE NEWSWIRE) -- Jeffrey Scott Yablon has received an Industry Recognition Award from Clinical Research Malaysia for his outstanding efforts in promoting Malaysia as a preferred destination for Industry Sponsored Research (ISR).
 
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/528a88b7-a898-4d3f-840e-ec343f0b0002
 
“I’m honored to have been recognized by Clinical Research Malaysia with this award,” said Yablon. “Expanding business in Malaysia has opened up multiple opportunities for many. Malaysia offers unique benefits to the clinical research industry, and I’m truly honored to have been recognized for my efforts on behalf of the region.”
 
At CRM Industry Dialogue held on March 16, 2016, Yablon was recognized for his dual efforts in promoting clinical research in Malaysia and developing the clinical research ecosystem in the country.
 
Yablon, who heads the Asia/Pacific operations for InClinica – a global clinical CRO – has more than 20 years of experience in life science management. A long-time advocate of expanding business opportunities in Asia, Yablon has also been responsible for developing a clinical research training and certificate program for InClinica.
 
Yablon has a B.A. degree from Stockton University, an M.S. in Clinical Pharmacology from Stony Brook University and an EMBA in International Business Management from Fairleigh Dickinson University.
 
 
SOURCE : InClinica

Contact:
John Reynolds
+ 1 610-228-0730
john.reynolds@buchananpr.com

--BERNAMA 

 
 
 

Copyright © 2024 MREM . All rights reserved.